Transition from Multiple Daily Injections (MDI) to Omnipod 5 Automated Insulin Delivery System Improves A1C in Type 1 Diabetes (T1D)

被引：0
|
作者：
Shah, Viral
Criego, Amy B.
Carlson, Anders L.
Bhargava, Anuj
Bode, Bruce W.
Brown, Sue A.
Forlenza, Gregory P.
Levy, Carol J.
Mehta, Sanjeev N.
Laffel, Lori M.
Aleppo, Grazia
Buckingham, Bruce A.
Desalvo, Daniel
Hirsch, Irl B.
Macleish, Sarah A.
Pinsker, Jordan E.
Ly, Trang T.
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-716-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
716-P
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Safety evaluation of the Omnipod® 5 automated insulin delivery system over three months of use in adults and children with type 1 diabetes
    Forlenza, G. P.
    Brown, S. A.
    Ly, T. T.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 295 - 296
  • [42] Impact of A1c and zBMI on Blood Pressure (BP) Over Time in Pediatric Type 1 Diabetes (T1D)
    Katz, Michelle
    Ding, Ming
    Telo, Gabriela H.
    Dougher, Carly E.
    Laffel, Lori M.
    DIABETES, 2015, 64 : A368 - A368
  • [43] Text-Message Intervention for Teens with Type 1 Diabetes (T1D) Preserves A1c: Results of an RCT
    Laffel, Lori M.
    Volkening, Lisa K.
    Levy, Wendy L.
    Butler, Deborah A.
    Anderson, Barbara J.
    DIABETES, 2017, 66 : LB52 - LB52
  • [44] Glycemic Improvement in 5,094 Pediatric Patients with Type 1 Diabetes (T1D) Using the Omnipod Insulin Management System over First 90 Days of Use
    Desalvo, Daniel
    Aleppo, Grazia
    Lauand, Felipe
    Huyett, Lauren M., Sr.
    Jantz, Jay
    Chang, Albert
    Vienneau, Todd
    Ly, Trang T.
    DIABETES, 2021, 70
  • [45] Motivation and Attitudinal Assessment in Patients with T1D Using Multiple Daily Injections or Insulin Pump Therapy
    Alford, Jordin
    Koobatian, Maxwell
    Daigle, Ben
    Mathews, Kieron
    Dias, Louis
    DIABETES, 2019, 68
  • [46] Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin Injections
    Castle, Jessica R.
    Wilson, Leah M.
    Tyler, Nichole S.
    Espinoza, Alejandro Z.
    Mosquera-Lopez, Clara M.
    Kushner, Taisa
    Young, Gavin M.
    Pinsonault, Joseph
    Dodier, Robert H.
    Hilts, Wade W.
    Oganessian, Sos M.
    Branigan, Deborah L.
    Gabo, Virginia B.
    Eom, Jae H.
    Ramsey, Katrina
    El Youssef, Joseph
    Cafazzo, Joseph A.
    Winters-Stone, Kerri
    Jacobs, Peter G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (12) : 892 - 897
  • [47] Comparison of glycemic outcomes in patients with type 1 diabetes (T1DM) on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI) therapy
    Mathur, R
    Sosa, M
    Somma, L
    Peters, AL
    DIABETES, 2002, 51 : A107 - A107
  • [48] Long-Term Use of Omnipod® Insulin Management System Associated with Lower A1c in Adults with Established Diabetes and A1c=8%
    Tinsley, Liane J.
    Laffel, Lori M.
    Guo, Zijing
    Naik, Nisha
    Layne, Jennifer E.
    Ly, Trang T.
    Mehta, Sanjeev N.
    DIABETES, 2018, 67
  • [49] Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)
    Petrovski, Goran
    Al Khalaf, Fawziya
    Campbell, Judith
    Day, Emma
    Almajaly, Douha
    Hussain, Khalid
    Pasha, Maheen
    Umer, Fareeda
    Hamdan, Manar
    Khalifa, Amel
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [50] GLYCEMIC IMPROVEMENT IN 1,311 PATIENTS WITH TYPE 1 DIABETES (T1D) USING THE OMNIPOD DASH® INSULIN MANAGEMENT SYSTEM OVER FIRST 90 DAYS OF USE
    Aleppo, G.
    Desalvo, D.
    Lauand, F.
    Huyett, L.
    Jantz, J.
    Chang, A.
    Vienneau, T.
    Ly, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A51 - A51
12345